comparemela.com

Page 14 - Clinical Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The U S Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program

Vivoryon Therapeutics N V Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates

24.04.2024 - Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date .

Protara Therapeutics (TARA) Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC

Protara Therapeutics (TARA) Announces Positive Three-Month Data from TARA-002 Clinical Program in NMIBC
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Protara Therapeutics Announces Positive Three-Month Data From TARA-002 Clinical Program In NMIBC

Protara Therapeutics Announces Positive Three-Month Data From TARA-002 Clinical Program In NMIBC
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.